FDA Cardio-Renal Head Throckmorton Named CDER Acting Deputy
This article was originally published in The Tan Sheet
Executive Summary
FDA Cardio-Renal Drug Products Division Director Douglas Throckmorton, MD, is moving up to the position of acting deputy director of CDER, effective May 3